Moderna's coronavirus vaccine approval - only after US elections

Moderna Inc said on Wednesday it will not be ready to apply for emergency approval for its potential coroanvirus vaccine before the US presidential elections in November, the Financial Times reported.
The company's chief executive officer, Stéphane Bancel, told FT that he did not expect to have full approval to distribute the drug to all sections of the US population until next spring. 
Moderna did not immediately respond to Reuters request for comment.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy